肝炎肝硬化患者围手术期应用全静脉麻醉与静吸复合麻醉的疗效比较
Comparison of the Efficacy of Perioperative Total Intravenous Anesthesia and Intravenous Inhalation Combined Anesthesia in Patients with Hepatitis and Cirrhosis
摘要: 目的:比较肝炎肝硬化患者应用全静脉麻醉和静吸复合麻醉的临床疗效及不良反应的差异,分析肝炎肝硬化患者围手术期最佳麻醉方式。方法:选择行择期手术的肝炎肝硬化患者82例,随机分成2组,每组各41例。全静脉组应用丙泊酚全凭静脉麻醉,复合组采用异氟醚及丙泊酚静吸复合麻醉。于麻醉前(T0)、拔管后60 min (T1)及术后1 d (T2)、3 d (T3)时间点,分别比较2组改良Aldrete评分、自由基指标的差异。术后记录比较2组呛咳反应及术后恶心呕吐(post-operative nausea and vomiting, PONV)等并发症发生率的差异。结果:复合组与全静脉组的T0时刻2组患者改良Aldrete评分、血清超氧化物歧化酶(superoxide dismutase, SOD)及丙二醛(malondialdehyde, MDA)水平无显著差异(P > 0.05);T1、T2及T3时刻,复合组改良Aldrete评分、血清SOD水平均高于全静脉组(P < 0.05),血清MDA低于全静脉组(P < 0.05)。术后2组呛咳反应及PONV发生率无显著差异(P > 0.05)。结论:肝炎肝硬化患者围手术期应用静吸复合麻醉能显著提高临床疗效,减轻氧自由基,安全性较好。
Abstract: Objective: To compare the clinical efficacy and adverse reactions of total intravenous anesthesia and combined intravenous and inhalation anesthesia in patients with hepatitis and cirrhosis, and to an-alyze the best perioperative anesthesia method for patients with hepatitis and cirrhosis. Method: 82 patients with hepatitis and cirrhosis who underwent elective surgery were randomly divided into 2 groups, with 41 patients in each group. The total intravenous group received intravenous anesthesia with propofol, while the composite group received intravenous anesthesia with isoflu-rane and propofol. At the time points before anesthesia (T0), 60 minutes after extubation (T1), and 1 day (T2) and 3 days (T3) after surgery, the differences in the modified Aldrete score and free rad-ical index between the two groups were compared. The differences in the incidence of coughing re-actions and postoperative nausea and vomiting (PONV) complications between the two groups after surgery were compared. Results: There was no significant difference between the composite group and the whole vein group in the modified Aldrete score, serum superoxide dismutase (SOD) and malondialdehyde (MDA) levels at T0 time between the two groups (P > 0.05); At T1, T2, and T3, the modified Aldrete score and serum SOD level in the composite group were higher than those in the whole vein group (P < 0.05), while serum MDA was lower than those in the whole vein group (P < 0.05). There was no significant difference in cough response and PONV incidence between the two groups after surgery (P > 0.05). Conclusion: The perioperative use of intravenous and inhalation combined anesthesia in patients with hepatitis and cirrhosis can significantly improve clinical effi-cacy, reduce oxygen free radicals, and have good safety.
文章引用:汪艳萍, 许宜珍, 古丽亚科夫, 袁应川, 陈政文, 杜健华. 肝炎肝硬化患者围手术期应用全静脉麻醉与静吸复合麻醉的疗效比较[J]. 临床医学进展, 2023, 13(6): 9397-9402. https://doi.org/10.12677/ACM.2023.1361315

参考文献

[1] 解东明. 研究静-吸复合麻醉和全凭静脉麻醉对肝炎肝硬化患者围术期免疫功能的影响[J]. 益寿宝典, 2020, 10(23): 119-119.
[2] 任益锋, 郑孝振, 展鹏远. 麻醉药物及麻醉方式对慢性肝炎手术患者围术期免疫功能的影响[C]//第十届全国疑难及重症肝病大会. 第十届全国疑难及重症肝病大会论文集. 苏州: 全国疑难及重症肝病攻关协作组, 吴阶平医学基金会, 北京肝胆相照公益基金会, 北京医药科学技术发展协会, 2019: 208.
[3] 敖胜福. 观察静-吸复合麻醉和全凭静脉麻醉对肝炎肝硬化患者围术期免疫功能的影响[J]. 饮食保健, 2020, 7(16): 61-62.
[4] Sn, A., Ak, A., Fm, B., et al. (2021) A Randomized Controlled Trial Evaluating Inhalation and Intravenous Anesthesia for Laparoscopic Cholecystectomy. International Journal of Surgery Open, 28, 1-7. [Google Scholar] [CrossRef
[5] Kim, S.H., Ju, H.M., Choi, C.H., et al. (2021) Inhalational versus Intravenous Maintenance of Anesthesia for Quality of Recovery in Patients Undergoing Corrective Lower Limb Osteot-omy: A Randomized Controlled Trial. PLOS ONE, 16, e0247089. [Google Scholar] [CrossRef] [PubMed]
[6] Bhagat, H., Sharma, T., Mahajan, S., et al. (2021) Intravenous versus Inhalational Anesthesia Trial for Outcome Following Intracranial Aneurysm Surgery: A Prospective Randomized Controlled Study. Surgical Neurology International, 12, 300. [Google Scholar] [CrossRef
[7] 胡元威. 肝炎肝硬化患者术中两种麻醉方式对肝肾功能与免疫指标的影响[J]. 大医生, 2021, 6(11): 13-15.
[8] 窦雅丽, 杨付明. 丙泊酚与七氟醚对肝炎肝硬化围术期的影响[J]. 中国继续医学教育, 2020, 12(29): 144-147.
[9] 罗洁, 张娟, 汪建辉, 等. 丙泊酚与七氟醚复合麻醉对肝炎肝硬化患者围术期凝血功能的影响[J]. 当代医学, 2019, 25(16): 10-12.
[10] 毛文艳, 姜虎飞, 鲁媛媛. 腹腔镜子宫切除患者瑞芬太尼、丙泊酚复合异氟醚的麻醉效果及对术后应激反应的影响[J]. 河北医药, 2022, 44(6): 895-897+901.